Regulations

8 posts

Colossal Wrongdoings by Big Pharma – Ranbaxy Scandal – Asrar Qureshi’s Blog Post #1093

The Ranbaxy scandal illustrates significant fraud within a major Indian pharmaceutical company that misled regulatory bodies and compromised drug safety. Whistleblower Dinesh Thakur’s revelations led to a $500 million settlement, exposing flaws in oversight and raising questions about generics. It’s a vital lesson on ethical standards and regulatory vigilance in the industry.
Share
View Post
  • 6 min

Five AI Trends to Watch in 2025 (and Beyond) – Asrar Qureshi’s Blog Post #1061

Asrar Qureshi’s blog outlines five significant AI trends expected by 2025. These include the democratization of coding through AI tools, the creation of high-quality AI-generated films, the rise of autonomous AI agents, improving affordability and performance of AI technologies, and an ongoing AI development surge amidst limited government regulation.
Share
View Post
  • 5 min

Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005

Asrar Qureshi’s blog post discusses the unique ethical challenges of pharmaceutical marketing, emphasizing the distinction between customers (doctors) and consumers (patients). It highlights issues like misleading advertising, targeting vulnerable populations, off-label promotions, exaggerated disease prevalence, and undue influence on healthcare decision-making. Collaboration is essential to promote ethical practices in the industry.
Share
View Post
  • 6 min

Healthcare Landscape in Pakistan – Sum Up – Asrar Qureshi’s Blog Post #987

This is Asrar Qureshi’s 12th Pharma Veterans blog post on Pakistan’s healthcare system. Strengths include advanced facilities, quality doctors, quick access to healthcare and drugs, and advanced surgical techniques. However, issues like inadequate resources, low government spending, private healthcare growth, disease burden, drug misuse, and non-compliance pose significant challenges.
Share